In order to identify the best threshold values for the EGFR TMDA, we first analysed with this method a training set of 30 NSCLC and 6 CRC samples, which were included as negative controls due to the rare presence of EGFR mutations in this tumor type. This evidence concerns the gene EGFR and colorectal carcinoma.